本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Immunocore Holdings plc

37.29
+1.343.71%
成交量:9.55万
成交额:351.27万
市值:18.84亿
市盈率:-64.06
高:37.29
开:35.86
低:35.86
收:35.95
52周最高:39.33
52周最低:23.15
股本:5,053.04万
流通股本:3,757.24万
量比:0.50
换手率:0.25%
股息:- -
股息率:- -
每股收益(TTM):-0.5821
每股收益(LYR):-1.0219
净资产收益率:-7.55%
总资产收益率:-1.55%
市净率:4.75
市盈率(LYR):-36.49

数据加载中...

2022/02/15

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/10

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/10/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/20

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/04/19

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/12

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/03/25

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/02/03

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/03

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/02

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

SEC问询函

CORRESP [Cover] - Correspondence
2021/02/01

[修订]招股说明书

F-1/A [Amend] - Registration statement for certain foreign private issuers
2021/01/21

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/15

SEC问询函

CORRESP [Cover] - Correspondence
2021/01/15

招股说明书

F-1 - Registration statement for certain foreign private issuers
2016/04/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals